TreeWAS – Variant ID: rs115686841

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
D68.2 Hereditary deficiency of other clotting factors	1.000	0.000
I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities	1.000	0.000
D68 Other coagulation defects	1.000	0.000
Z86.7 Personal history of diseases of the circulatory system	1.000	0.000
Chapter IX Diseases of the circulatory system	1.000	0.000
I80 Phlebitis and thrombophlebitis	1.000	0.000
Chapter VII Diseases of the eye and adnexa	1.000	0.000
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified	1.000	0.000
# Top node	1.000	0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.999	0.001
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.999	0.001
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.999	0.001
I26 Pulmonary embolism	0.999	0.001
I26.9 Pulmonary embolism without mention of acute cor pulmonale	0.999	0.001
H40-H42 Glaucoma	0.998	0.002
H40 Glaucoma	0.996	0.004
Chapter II Neoplasms	0.974	0.026
H40.1 Primary open-angle glaucoma	0.972	0.028
H30-H36 Disorders of choroid and retina	0.957	0.043
C15-C26 Malignant neoplasms of digestive organs	0.953	0.047
D68.5 Primary Thrombophilia	0.938	0.062
H40.9 Glaucoma, unspecified	0.937	0.063
I60-I69 Cerebrovascular diseases	0.937	0.063
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.936	0.064
D10-D36 Benign neoplasms	0.930	0.070
D68.8 Other specified coagulation defects	0.929	0.071
I80.1 Phlebitis and thrombophlebitis of femoral vein	0.924	0.076
D25 Leiomyoma of uterus	0.922	0.078
H40.0 Glaucoma suspect	0.893	0.107
D17 Benign lipomatous neoplasm	0.886	0.114
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.877	0.123
C25 Malignant neoplasm of pancreas	0.874	0.126
D25.9 Leiomyoma of uterus, unspecified	0.872	0.128
Chapter I Certain infectious and parasitic diseases	0.869	0.131
D25.0 Submucous leiomyoma of uterus	0.868	0.132
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.866	0.134
H35 Other retinal disorders	0.863	0.137
C18 Malignant neoplasm of colon	0.862	0.138
H50 Other strabismus	0.853	0.147
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.852	0.148
I82 Other venous embolism and thrombosis	0.844	0.156
H53-H54 Visual disturbances and blindness	0.834	0.166
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.828	0.172
H46-H48 Disorders of optic nerve and visual pathways	0.827	0.172
I87 Other disorders of veins	0.827	0.172
D69 Purpura and other haemorrhagic conditions	0.825	0.175
D68.6 Other Thrombophilia	0.825	0.175
I64 Stroke, not specified as haemorrhage or infarction	0.811	0.189
I69 Sequelae of cerebrovascular disease	0.809	0.190
H33 Retinal detachments and breaks	0.808	0.192
C60-C63 Malignant neoplasms of male genital organs	0.808	0.192
C18.9 Colon, unspecified	0.807	0.193
C90 Multiple myeloma and malignant plasma cell neoplasms	0.806	0.194
D36 Benign neoplasm of other and unspecified sites	0.802	0.198
H36 Retinal disorders in diseases classified elsewhere	0.802	0.198
C25.0 Head of pancreas	0.799	0.201
C18.2 Ascending colon	0.791	0.209
H43-H45 Disorders of vitreous body and globe	0.791	0.209
H52 Disorders of refraction and accommodation	0.791	0.209
D25.1 Intramural leiomyoma of uterus	0.788	0.211
H40.8 Other glaucoma	0.788	0.212
I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities	0.788	0.212
C26 Malignant neoplasm of other and ill-defined digestive organs	0.785	0.215
H50.1 Divergent concomitant strabismus	0.781	0.219
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.778	0.222
I80.9 Phlebitis and thrombophlebitis of unspecified site	0.776	0.224
I95-I99 Other and unspecified disorders of the circulatory system	0.776	0.224
H35.8 Other specified retinal disorders	0.775	0.225
H40.2 Primary angle-closure glaucoma	0.770	0.230
D68.0 Von Willebrand's disease	0.770	0.230
D31 Benign neoplasm of eye and adnexa	0.770	0.230
H53 Visual disturbances	0.770	0.230
D80-D89 Certain disorders involving the immune mechanism	0.763	0.237
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.759	0.241
I89 Other non-infective disorders of lymphatic vessels and lymph nodes	0.757	0.243
I62 Other nontraumatic intracranial haemorrhage	0.756	0.244
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.750	0.250
D23 Other benign neoplasms of skin	0.748	0.252
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.747	0.253
D28 Benign neoplasm of other and unspecified female genital organs	0.747	0.253
D68.9 Coagulation defect, unspecified	0.746	0.254
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.746	0.254
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.737	0.263
H40.5 Glaucoma secondary to other eye disorders	0.736	0.264
Chapter XXII Codes for special purposes	0.733	0.266
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.728	0.272
C91 Lymphoid leukaemia	0.728	0.272
I67 Other cerebrovascular diseases	0.726	0.274
Z86 Personal history of certain other diseases	0.726	0.274
C45 Mesothelioma	0.723	0.277
H35.3 Degeneration of macula and posterior pole	0.720	0.280
D68.4 Acquired coagulation factor deficiency	0.717	0.283
D68.1 Hereditary factor XI deficiency	0.717	0.283
I00-I02 Acute rheumatic fever	0.717	0.283
I88 Nonspecific lymphadenitis	0.717	0.283
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
I87.8 Other specified disorders of veins	0.717	0.283
D67 Hereditary factor IX deficiency	0.717	0.283
D66 Hereditary factor VIII deficiency	0.717	0.283
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.717	0.283
B25-B34 Other viral diseases	0.717	0.283
I28 Other diseases of pulmonary vessels	0.716	0.284
D55-D59 Haemolytic anaemias	0.716	0.284
I26.0 Pulmonary embolism with mention of acute cor pulmonale	0.716	0.284
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.715	0.285
H42 Glaucoma in diseases classified elsewhere	0.715	0.285
H40.6 Glaucoma secondary to drugs	0.714	0.286
H40.4 Glaucoma secondary to eye inflammation	0.714	0.286
H40.3 Glaucoma secondary to eye trauma	0.714	0.286
D11 Benign neoplasm of major salivary glands	0.714	0.286
I81 Portal vein thrombosis	0.714	0.286
D23.6 Skin of upper limb, including shoulder	0.713	0.287
I82.8 Embolism and thrombosis of other specified veins	0.712	0.287
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck	0.709	0.291
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.709	0.291
D17.9 Benign lipomatous neoplasm, unspecified	0.709	0.291
C90.2 Plasmacytoma, extramedullary	0.708	0.292
C21 Malignant neoplasm of anus and anal canal	0.707	0.293
C20 Malignant neoplasm of rectum	0.706	0.294
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.703	0.297
I27 Other pulmonary heart diseases	0.701	0.299
A80-A89 Viral infections of the central nervous system	0.701	0.299
Z92 Personal history of medical treatment	0.699	0.301
H33.2 Serous retinal detachment	0.698	0.302
B35-B49 Mycoses	0.698	0.302
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.698	0.302
C40-C41 Malignant neoplasms of bone and articular cartilage	0.698	0.302
Chapter XXI Factors influencing health status and contact with health services	0.698	0.302
B20-B24 Human immunodeficiency virus [HIV] disease	0.696	0.304
D10 Benign neoplasm of mouth and pharynx	0.696	0.304
Z88 Personal history of allergy to drugs, medicaments and biologocal substances	0.696	0.304
Z80-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status	0.696	0.304
Z92.1 Personal history of long-term (current) use of anticoagulants	0.695	0.305
H25-H28 Disorders of lens	0.693	0.307
H36.0 Diabetic retinopathy	0.691	0.309
D23.5 Skin of trunk	0.691	0.309
C90.0 Multiple myeloma	0.691	0.309
H32 Chorioretinal disorders in diseases classified elsewhere	0.686	0.314
H31 Other disorders of choroid	0.686	0.314
H30 Chorioretinal inflammation	0.686	0.314
B50-B64 Protozoal diseases	0.685	0.315
C25.9 Pancreas, unspecified	0.685	0.315
I10-I15 Hypertensive diseases	0.685	0.315
D30 Benign neoplasm of urinary organs	0.683	0.317
C15 Malignant neoplasm of oesophagus	0.683	0.317
C61 Malignant neoplasm of prostate	0.683	0.317
C17 Malignant neoplasm of small intestine	0.683	0.317
C23 Malignant neoplasm of gallbladder	0.683	0.317
A15-A19 Tuberculosis	0.682	0.318
C19 Malignant neoplasm of rectosigmoid junction	0.681	0.319
H35.5 Hereditary retinal dystrophy	0.681	0.319
Chapter V Mental and behavioural disorders	0.680	0.320
I63 Cerebral infarction	0.679	0.321
Z88.0 Personal history of allergy to penicillin	0.674	0.326
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.673	0.327
I68 Cerebrovascular disorders in diseases classified elsewhere	0.672	0.328
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.672	0.328
B99-B99 Other infectious diseases	0.671	0.328
H53.0 Amblyopia ex anopsia	0.671	0.329
H51 Other disorders of binocular movement	0.671	0.329
H34 Retinal vascular occlusions	0.671	0.329
H49 Paralytic strabismus	0.670	0.330
B15-B19 Viral hepatitis	0.669	0.331
H47 Other disorders of optic [2nd] nerve and visual pathways	0.668	0.332
D29 Benign neoplasm of male genital organs	0.667	0.333
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.667	0.333
D19 Benign neoplasm of mesothelial tissue	0.667	0.333
D16 Benign neoplasm of bone and articular cartilage	0.667	0.333
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.667	0.333
D14 Benign neoplasm of middle ear and respiratory system	0.667	0.333
D36.1 Peripheral nerves and autonomic nervous system	0.665	0.335
C26.0 Intestinal tract, part unspecified	0.665	0.335
D69.9 Haemorrhagic condition, unspecified	0.662	0.338
Z86.0 Personal history of other neoplasms	0.662	0.338
D37-D48 Neoplasms of uncertain or unknown behaviour	0.657	0.343
Z92.4 Personal history of major surgery, not elsewhere classified	0.657	0.343
C81 Hodgkin's disease	0.656	0.344
D31.3 Choroid	0.655	0.345
D35 Benign neoplasm of other and unspecified endocrine glands	0.655	0.345
D25.2 Subserosal leiomyoma of uterus	0.654	0.346
H35.6 Retinal haemorrhage	0.654	0.346
B07 Viral warts	0.654	0.346
D36.7 Other specified sites	0.650	0.349
B90-B94 Sequelae of infectious and parasitic diseases	0.650	0.350
M65-M68 Disorders of synovium and tendon	0.649	0.351
C51-C58 Malignant neoplasms of female genital organs	0.649	0.351
H46 Optic neuritis	0.647	0.353
Z88.8 Personal history of allergy to other drugs, medicaments and biological substances	0.646	0.354
H50.9 Strabismus, unspecified	0.645	0.355
I82.2 Embolism and thrombosis of vena cava	0.640	0.360
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.637	0.363
H52.1 Myopia	0.637	0.363
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.636	0.364
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.636	0.364
D17.4 Benign lipomatous neoplasm of intrathoracic organs	0.635	0.365
H35.7 Separation of retinal layers	0.634	0.366
C18.4 Transverse colon	0.633	0.366
C18.3 Hepatic flexure	0.633	0.367
C45.0 Mesothelioma of pleura	0.631	0.369
D69.3 Idiopathic thrombocytopenic purpura	0.630	0.370
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.630	0.370
Z92.6 Personal history of chemotherapy for neoplastic disease	0.629	0.371
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.628	0.371
C95 Leukaemia of unspecified cell type	0.628	0.371
C94 Other leukaemias of specified cell type	0.628	0.371
C93 Monocytic leukaemia	0.628	0.371
C88 Malignant immunoproliferative diseases	0.628	0.371
C86 Other specified types of T/NK-cell lymphoma	0.628	0.371
C84 Peripheral and cutaneous T-cell lymphomas	0.628	0.371
H55-H59 Other disorders of eye and adnexa	0.628	0.372
H53.2 Diplopia	0.628	0.372
I12 Hypertensive renal disease	0.628	0.372
H44 Disorders of globe	0.627	0.372
M50-M54 Other dorsopathies	0.628	0.372
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.626	0.374
C25.8 Overlapping lesion of pancreas	0.626	0.374
C25.7 Other parts of pancreas	0.626	0.374
C25.4 Endocrine pancreas	0.626	0.374
C25.3 Pancreatic duct	0.626	0.374
C25.2 Tail of pancreas	0.626	0.374
C25.1 Body of pancreas	0.626	0.374
H10-H13 Disorders of conjunctiva	0.626	0.374
I61 Intracerebral haemorrhage	0.624	0.376
B85-B89 Pediculosis, acariasis and other infestations	0.623	0.377
B65-B83 Helminthiases	0.623	0.377
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.623	0.377
A75-A79 Rickettsioses	0.623	0.377
A70-A74 Other diseases caused by chlamydiae	0.623	0.377
A65-A69 Other spirochaetal diseases	0.623	0.377
A50-A64 Infections with a predominantly sexual mode of transmission	0.623	0.377
A20-A28 Certain zoonotic bacterial diseases	0.623	0.377
D33 Benign neoplasm of brain and other parts of central nervous system	0.621	0.379
H50.0 Convergent concomitant strabismus	0.621	0.379
C91.1 Chronic lymphocytic leukaemia	0.621	0.379
I83 Varicose veins of lower extremities	0.620	0.380
H35.2 Other proliferative retinopathy	0.619	0.381
H35.1 Retinopathy of prematurity	0.619	0.381
C18.8 Overlapping lesion of colon	0.618	0.382
C18.1 Appendix	0.618	0.382
C16 Malignant neoplasm of stomach	0.618	0.382
Chapter VIII Diseases of the ear and mastoid process	0.618	0.382
Q80-Q89 Other congenital malformations	0.615	0.385
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.614	0.386
I99 Other and unspecified disorders of circulatory system	0.613	0.387
I87.1 Compression of vein	0.613	0.387
H50.8 Other specified strabismus	0.612	0.388
H50.6 Mechanical strabismus	0.612	0.388
H50.5 Heterophoria	0.612	0.388
H50.4 Other and unspecified heterotropia	0.612	0.388
H50.3 Intermittent heterotropia	0.612	0.388
H50.2 Vertical strabismus	0.612	0.388
H53.8 Other visual disturbances	0.612	0.388
I98 Other disorders of circulatory system in diseases classified elsewhere	0.611	0.389
D69.6 Thrombocytopenia, unspecified	0.610	0.390
C50-C50 Malignant neoplasm of breast	0.609	0.391
H52.0 Hypermetropia	0.608	0.392
H52.2 Astigmatism	0.606	0.394
C92 Myeloid leukaemia	0.606	0.394
D26 Other benign neoplasms of uterus	0.605	0.395
I82.9 Embolism and thrombosis of unspecified vein	0.605	0.395
I82.3 Embolism and thrombosis of renal vein	0.605	0.395
I82.1 Thrombophlebitis migrans	0.605	0.395
I82.0 Budd-Chiari syndrome	0.605	0.395
I86 Varicose veins of other sites	0.604	0.395
I80.8 Phlebitis and thrombophlebitis of other sites	0.604	0.396
D28.1 Vagina	0.604	0.396
H33.5 Other retinal detachments	0.601	0.398
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.600	0.400
C24.1 Ampulla of Vater	0.600	0.400
H35.9 Retinal disorder, unspecified	0.599	0.401
C64-C68 Malignant neoplasms of urinary tract	0.599	0.401
I67.9 Cerebrovascular disease, unspecified	0.599	0.401
F00-F09 Organic, including symptomatic, mental disorders	0.599	0.401
D21 Other benign neoplasms of connective and other soft tissue	0.598	0.402
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.596	0.404
B34 Viral infection of unspecified site	0.596	0.404
H33.0 Retinal detachment with retinal break	0.596	0.404
C49 Malignant neoplasm of other connective and soft tissue	0.593	0.406
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.593	0.406
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.593	0.406
C46 Kaposi's sarcoma	0.593	0.406
M91-M94 Chondropathies	0.594	0.406
H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere	0.593	0.407
I87.9 Disorder of vein, unspecified	0.593	0.407
I87.0 Postphlebitic syndrome	0.593	0.407
D69.8 Other specified haemorrhagic conditions	0.591	0.409
D69.5 Secondary thrombocytopenia	0.591	0.409
D69.4 Other primary thrombocytopenia	0.591	0.409
D69.2 Other nonthrombocytopenic purpura	0.591	0.409
D69.1 Qualitative platelet defects	0.591	0.409
D69.0 Allergic purpura	0.591	0.409
I67.8 Other specified cerebrovascular diseases	0.591	0.409
I89.0 Lymphoedema, not elsewhere classified	0.591	0.409
C62 Malignant neoplasm of testis	0.589	0.411
Z86.3 Personal history of endocrine, nutritional and metabolic diseases	0.589	0.411
M70-M79 Other soft tissue disorders	0.589	0.411
Chapter XV Pregnancy, childbirth and the puerperium	0.588	0.412
D27 Benign neoplasm of ovary	0.588	0.412
H53.4 Visual field defects	0.587	0.413
H43 Disorders of vitreous body	0.587	0.413
Z88.9 Personal history of allergy to unspecified drugs, medicaments and biological substances	0.585	0.415
Z88.3 Personal history of allergy to other anti-infective agents	0.583	0.417
M51 Other intervertebral disk disorders	0.581	0.419
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.580	0.419
I69.1 Sequelae of intracerebral haemorrhage	0.580	0.419
A87 Viral meningitis	0.580	0.420
H35.4 Peripheral retinal degeneration	0.580	0.420
H33.4 Traction detachment of retina	0.580	0.420
H33.1 Retinoschisis and retinal cysts	0.580	0.420
B00 Herpesviral [herpes simplex] infections	0.580	0.420
C63 Malignant neoplasm of other and unspecified male genital organs	0.579	0.421
C60 Malignant neoplasm of penis	0.579	0.421
Q50-Q56 Congenital malformations of genital organs	0.579	0.421
C90.3 Solitary plasmacytoma	0.578	0.422
C90.1 Plasma cell leukaemia	0.578	0.422
Z92.0 Personal history of contraception	0.578	0.422
I05-I09 Chronic rheumatic heart diseases	0.577	0.423
D10.1 Tongue	0.575	0.425
D23.2 Skin of ear and external auricular canal	0.575	0.425
D36.9 Benign neoplasm of unspecified site	0.575	0.425
D36.0 Lymph nodes	0.575	0.425
H36.8 Other retinal disorders in diseases classified elsewhere	0.575	0.425
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.573	0.427
B24 Unspecified human immunodeficiency virus [HIV] disease	0.573	0.427
C69 Malignant neoplasm of eye and adnexa	0.573	0.427
M67 Other disorders of synovium and tendon	0.572	0.428
Q38-Q45 Other congenital malformations of the digestive system	0.571	0.429
C83 Diffuse non-Hodgkin's lymphoma	0.569	0.431
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.567	0.433
H52.7 Disorder of refraction, unspecified	0.567	0.433
H52.6 Other disorders of refraction	0.567	0.433
H52.5 Disorders of accommodation	0.567	0.433
H52.4 Presbyopia	0.567	0.433
H52.3 Anisometropia and aniseikonia	0.567	0.433
D11.9 Major salivary gland, unspecified	0.565	0.435
D45 Polycythaemia vera	0.565	0.435
I69.3 Sequelae of cerebral infarction	0.564	0.435
C18.6 Descending colon	0.564	0.436
I83.0 Varicose veins of lower extremities with ulcer	0.564	0.436
Chapter XX External causes of morbidity and mortality	0.564	0.436
Z88.2 Personal history of allergy to sulphonamides	0.563	0.437
I12.0 Hypertensive renal disease with renal failure	0.563	0.437
C26.9 Ill-defined sites within the digestive system	0.563	0.437
C26.8 Overlapping lesion of digestive system	0.563	0.437
C26.1 Spleen	0.563	0.437
H20 Iridocyclitis	0.563	0.437
H17 Corneal scars and opacities	0.563	0.437
B37 Candidiasis	0.561	0.439
C18.5 Splenic flexure	0.560	0.440
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.560	0.440
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.558	0.442
C45.9 Mesothelioma, unspecified	0.557	0.442
I60 Subarachnoid haemorrhage	0.557	0.442
I65.2 Occlusion and stenosis of carotid artery	0.557	0.443
I97 Postprocedural disorders of circulatory system, not elsewhere classified	0.556	0.443
I63.8 Other cerebral infarction	0.556	0.444
C01 Malignant neoplasm of base of tongue	0.555	0.445
B59 Pneumocystosis	0.554	0.446
H47.3 Other disorders of optic disk	0.553	0.447
C15.5 Lower third of oesophagus	0.553	0.447
D28.0 Vulva	0.553	0.447
H27 Other disorders of lens	0.553	0.447
D31.9 Eye, unspecified	0.552	0.448
D31.6 Orbit, unspecified	0.552	0.448
D31.5 Lachrymal gland and duct	0.552	0.448
D31.4 Ciliary body	0.552	0.448
D31.2 Retina	0.552	0.448
D31.1 Cornea	0.552	0.448
D31.0 Conjunctiva	0.552	0.448
I69.0 Sequelae of subarachnoid haemorrhage	0.552	0.448
H53.6 Night blindness	0.552	0.448
H53.5 Colour vision deficiencies	0.552	0.448
H53.3 Other disorders of binocular vision	0.552	0.448
A16 Respiratory tuberculosis, not confirmed bacteriologically or histologically	0.547	0.452
D84 Other immunodeficiencies	0.547	0.453
D83 Common variable immunodeficiency	0.547	0.453
D82 Immunodeficiency associated with other major defects	0.547	0.453
D81 Combined immunodeficiencies	0.547	0.453
D80 Immunodeficiency with predominantly antibody defects	0.547	0.453
M45-M49 Spondylopathies	0.547	0.453
Z94 Transplanted organ and tissue status	0.547	0.453
D86 Sarcoidosis	0.545	0.454
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.545	0.455
I85 Oesophageal varices	0.545	0.455
H33.3 Retinal breaks without detachment	0.545	0.455
M86-M90 Other osteopathies	0.544	0.456
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.544	0.456
Q35-Q37 Cleft lip and cleft palate	0.544	0.456
Q30-Q34 Congenital malformations of the respiratory system	0.544	0.456
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.544	0.456
Q00-Q07 Congenital malformations of the nervous system	0.544	0.456
I87.2 Venous insufficiency (chronic) (peripheral)	0.544	0.456
D17.7 Benign lipomatous neoplasm of other sites	0.543	0.456
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.544	0.456
H16 Keratitis	0.543	0.457
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified	0.543	0.457
I89.1 Lymphangitis	0.543	0.457
M51.0 Lumbar and other intervertebral disk disorders with myelopathy	0.542	0.458
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.542	0.458
I62.1 Nontraumatic extradural haemorrhage	0.542	0.458
O00-O08 Pregnancy with abortive outcome	0.540	0.460
D17.6 Benign lipomatous neoplasm of spermatic cord	0.538	0.461
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.538	0.462
H21 Other disorders of iris and ciliary body	0.538	0.462
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.538	0.462
H15 Disorders of sclera	0.538	0.462
H53.1 Subjective visual disturbances	0.538	0.462
D23.0 Skin of lip	0.536	0.463
C24.9 Biliary tract, unspecified	0.536	0.464
C24.8 Overlapping lesion of biliary tract	0.536	0.464
C24.0 Extrahepatic bile duct	0.536	0.464
D28.9 Female genital organ, unspecified	0.535	0.464
D28.7 Other specified female genital organs	0.535	0.464
D28.2 Uterine tubes and ligaments	0.535	0.464
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.535	0.465
B06 Rubella [German measles]	0.535	0.465
B05 Measles	0.535	0.465
B01 Varicella [chickenpox]	0.535	0.465
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.535	0.465
B04 Monkeypox	0.535	0.465
B03 Smallpox	0.535	0.465
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.534	0.465
B25 Cytomegaloviral disease	0.534	0.466
I89.8 Other specified non-infective disorders of lymphatic vessels and lymph nodes	0.532	0.468
M40-M43 Deforming dorsopathies	0.531	0.469
C21.1 Anal canal	0.531	0.469
B99 Other and unspecified infectious diseases	0.530	0.470
Z88.4 Personal history of allergy to anaesthetic agent	0.530	0.470
I27.0 Primary pulmonary hypertension	0.529	0.471
M60-M63 Disorders of muscles	0.528	0.472
M00-M03 Infectious arthropathies	0.528	0.472
M66 Spontaneous rupture of synovium and tendon	0.528	0.472
C18.0 Caecum	0.527	0.473
B18 Chronic viral hepatitis	0.526	0.474
Z22 Carrier of infectious disease	0.525	0.475
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.524	0.476
H53.9 Visual disturbance, unspecified	0.524	0.476
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.523	0.477
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.522	0.478
B35 Dermatophytosis	0.522	0.478
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.522	0.478
C70 Malignant neoplasm of meninges	0.522	0.478
D32 Benign neoplasm of meninges	0.522	0.478
C91.9 Lymphoid leukaemia, unspecified	0.522	0.478
C91.8 Mature B-cell leukaemia Burkitt-type	0.522	0.478
C91.7 Other lymphoid leukaemia	0.522	0.478
C91.6 Prolymphocytic leukaemia of T-cell type	0.522	0.478
C91.5 Adult T-cell leukaemia	0.522	0.478
C91.4 Hairy-cell leukaemia	0.522	0.478
C91.3 Prolymphocytic leukaemia	0.522	0.478
C91.2 Subacute lymphocytic leukaemia	0.522	0.478
C91.0 Acute lymphoblastic leukaemia	0.522	0.478
I67.7 Cerebral arteritis, not elsewhere classified	0.521	0.479
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.521	0.479
I67.5 Moyamoya disease	0.521	0.479
I67.4 Hypertensive encephalopathy	0.521	0.479
I67.3 Progressive vascular leukoencephalopathy	0.521	0.479
I67.0 Dissection of cerebral arteries, nonruptured	0.521	0.479
M96 Postprocedural musculoskeletal disorders, not elsewhere classified	0.520	0.480
C45.7 Mesothelioma of other sites	0.519	0.481
C45.2 Mesothelioma of pericardium	0.519	0.481
C45.1 Mesothelioma of peritoneum	0.519	0.481
H25 Senile cataract	0.519	0.481
D23.9 Skin, unspecified	0.518	0.482
D24 Benign neoplasm of breast	0.517	0.483
H18 Other disorders of cornea	0.516	0.484
I12.9 Hypertensive renal disease without renal failure	0.516	0.484
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.516	0.484
I02 Rheumatic chorea	0.514	0.486
I01 Rheumatic fever with heart involvement	0.514	0.486
I00 Rheumatic fever without mention of heart involvement	0.514	0.486
I88.9 Nonspecific lymphadenitis, unspecified	0.514	0.486
I88.8 Other nonspecific lymphadenitis	0.514	0.486
I88.1 Chronic lymphadenitis, except mesenteric	0.514	0.486
I88.0 Nonspecific mesenteric lymphadenitis	0.514	0.486
P90-P96 Other disorders originating in the perinatal period	0.514	0.486
P80-P83 Conditions involving the integument and temperature regulation of fetus and newborn	0.514	0.486
P75-P78 Digestive system disorders of fetus and newborn	0.514	0.486
P70-P74 Transitory endocrine and metabolic disorders specific to fetus and newborn	0.514	0.486
P50-P61 Haemorrhagic and haematological disorders of fetus and newborn	0.514	0.486
P35-P39 Infections specific to the perinatal period	0.514	0.486
P20-P29 Respiratory and cardiovascular disorders specific to the perinatal period	0.514	0.486
P10-P15 Birth trauma	0.514	0.486
P05-P08 Disorders related to length of gestation and fetal growth	0.514	0.486
P00-P04 Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery	0.514	0.486
B33 Other viral diseases, not elsewhere classified	0.514	0.486
B30 Viral conjunctivitis	0.514	0.486
B27 Infectious mononucleosis	0.514	0.486
B26 Mumps	0.514	0.486
I28.9 Disease of pulmonary vessels, unspecified	0.514	0.486
I28.8 Other specified diseases of pulmonary vessels	0.514	0.486
I28.1 Aneurysm of pulmonary artery	0.514	0.486
I28.0 Arteriovenous fistula of pulmonary vessels	0.514	0.486
D59 Acquired haemolytic anaemia	0.513	0.486
D58 Other hereditary haemolytic anaemias	0.513	0.486
D57 Sickle-cell disorders	0.513	0.486
D56 Thalassaemia	0.513	0.486
D55 Anaemia due to enzyme disorders	0.513	0.486
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.514	0.486
I65.9 Occlusion and stenosis of unspecified precerebral artery	0.513	0.487

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations